Peripheral Blood Transcriptomics of Cerebral Amyloid Angiopathy (CAA) in Lobar Intracerebral Hemorrhage
Description: Cerebral amyloid angiopathy (CAA) is characterized by amyloid deposition in small blood vessels in the brain. Several etiologies exist with the most common being sporadic CAA and the focus of this proposal. While there is no therapy for CAA, there is an unmet need for human studies to investigate regulatory mechanisms associated with CAA biology in the context of aging and neurovascular health. While pathology is the most accurate means to assess CAA in humans, the Boston Criteria v2.0 can classify CAA in patients with lobar intracerebral hemorrhage (L-ICH) with high sensitivity and specificity of 90% and 93%, respectively. The proposed studies are designed to build upon our recent preliminary results comparing deep and lobar ICH in which our data indicate evidence for amyloid processing pathways uniquely linked to the lobar ICH group. We will leverage this relationship to examine transcriptomic profiles of blood from patients with L-ICH that are split into groups with either highly probable or low likelihood of CAA. Analyses of the transcriptomes will identify regulated genes, pathways, and potential master regulator hub genes that are involved in CAA and contribute to L-ICH. We will also identify CAA-specific age-related genes by identifying the genes that correlate with increasing age in the L-ICH group with probable CAA, but not in the L-ICH group without CAA, since age itself is a significant CAA risk factor. Additionally, we will take advantage of these specific differences and use machine learning models to assess the gene transcripts as biomarkers for CAA status in L-ICH. Results from this study will help identify treatment and prevention targets in L-ICH in patients with or without CAA, and will build towards future diagnostic applications especially for people and patients where CAA status is less clear.
Funder: American Heart Association
Amount: $300,000
Funding type: research
Funder scheme: Transformational Project Award
Start date: 2025-07-01
End date: 2028-06-30
Investigator: Bradley Ander (lead)
Institutions: University of California System, University of California, Davis, The Regents of the University of California, on Behalf of its Davis Campus
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Funded outputs count: 0
Funder award ID: 25TPA1465267
OpenAlex ID: G4972915735
